Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-29 @ 12:28 AM
Study NCT ID:
NCT01282632
Status:
COMPLETED
Last Update Posted:
2011-01-25
First Post:
2011-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ro123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Anthony Levitt
Old Organization:
Sunnybrook Health Sciences Centre